?>
Logo

PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 401k Plan overview

Plan NamePHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN
Plan identification number 001

PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.
  • Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

PPD, INC. has sponsored the creation of one or more 401k plans.

Company Name:PPD, INC.
Employer identification number (EIN):561640186
NAIC Classification:325410

Additional information about PPD, INC.

Jurisdiction of Incorporation: Texas Secretary of State
Incorporation Date: 1991-06-26
Company Identification Number: 0008796506
Legal Registered Office Address: 300 INDUSTRY DR

PITTSBURGH
United States of America (USA)
15275

More information about PPD, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012022-01-01
0012021-01-01
0012020-01-01
0012019-01-01
0012018-01-01
0012017-01-01EVAN RENNEKER
0012016-01-01DEBRA MORELAND
0012015-01-01DEBRA MORELAND
0012014-01-01DEBRA J MORELAND
0012013-01-01DEBRA J MORELAND BRIAN S TUTTLE2014-10-15
0012012-01-01DEBRA MORELAND BRIAN TUTTLE2013-09-30
0012011-01-01DEBRA J MORELAND BRIAN TUTTLE2012-09-28
0012009-01-01DEBRA MORELAND

Plan Statistics for PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN

401k plan membership statisitcs for PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN

Measure Date Value
2022: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-0117,082
Total number of active participants reported on line 7a of the Form 55002022-01-0115,886
Number of retired or separated participants receiving benefits2022-01-0133
Number of other retired or separated participants entitled to future benefits2022-01-013,481
Total of all active and inactive participants2022-01-0119,400
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-0111
Total participants2022-01-0119,411
Number of participants with account balances2022-01-0116,539
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-011,279
2021: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-0114,092
Total number of active participants reported on line 7a of the Form 55002021-01-0114,003
Number of retired or separated participants receiving benefits2021-01-0126
Number of other retired or separated participants entitled to future benefits2021-01-013,043
Total of all active and inactive participants2021-01-0117,072
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-0110
Total participants2021-01-0117,082
Number of participants with account balances2021-01-0114,282
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-01767
2020: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-0112,799
Total number of active participants reported on line 7a of the Form 55002020-01-0111,350
Number of retired or separated participants receiving benefits2020-01-0111
Number of other retired or separated participants entitled to future benefits2020-01-012,719
Total of all active and inactive participants2020-01-0114,080
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-0112
Total participants2020-01-0114,092
Number of participants with account balances2020-01-0111,241
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-01592
2019: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-0111,583
Total number of active participants reported on line 7a of the Form 55002019-01-0110,122
Number of retired or separated participants receiving benefits2019-01-0127
Number of other retired or separated participants entitled to future benefits2019-01-012,496
Total of all active and inactive participants2019-01-0112,645
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-0111
Total participants2019-01-0112,656
Number of participants with account balances2019-01-0110,135
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-01531
2018: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-0111,113
Total number of active participants reported on line 7a of the Form 55002018-01-019,130
Number of retired or separated participants receiving benefits2018-01-0127
Number of other retired or separated participants entitled to future benefits2018-01-012,297
Total of all active and inactive participants2018-01-0111,454
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-0111
Total participants2018-01-0111,465
Number of participants with account balances2018-01-019,103
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-01546
2017: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-0110,474
Total number of active participants reported on line 7a of the Form 55002017-01-018,703
Number of retired or separated participants receiving benefits2017-01-0126
Number of other retired or separated participants entitled to future benefits2017-01-012,322
Total of all active and inactive participants2017-01-0111,051
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-019
Total participants2017-01-0111,060
Number of participants with account balances2017-01-018,729
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-01441
2016: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-019,786
Total number of active participants reported on line 7a of the Form 55002016-01-018,291
Number of retired or separated participants receiving benefits2016-01-0116
Number of other retired or separated participants entitled to future benefits2016-01-012,117
Total of all active and inactive participants2016-01-0110,424
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-0110
Total participants2016-01-0110,434
Number of participants with account balances2016-01-017,985
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-01414
2015: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-0110,719
Total number of active participants reported on line 7a of the Form 55002015-01-017,747
Number of retired or separated participants receiving benefits2015-01-0116
Number of other retired or separated participants entitled to future benefits2015-01-012,017
Total of all active and inactive participants2015-01-019,780
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-016
Total participants2015-01-019,786
Number of participants with account balances2015-01-017,327
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-01404
2014: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-018,314
Total number of active participants reported on line 7a of the Form 55002014-01-018,903
Number of retired or separated participants receiving benefits2014-01-0115
Number of other retired or separated participants entitled to future benefits2014-01-011,795
Total of all active and inactive participants2014-01-0110,713
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-016
Total participants2014-01-0110,719
Number of participants with account balances2014-01-016,706
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-01334
2013: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-017,813
Total number of active participants reported on line 7a of the Form 55002013-01-016,657
Number of retired or separated participants receiving benefits2013-01-0111
Number of other retired or separated participants entitled to future benefits2013-01-011,642
Total of all active and inactive participants2013-01-018,310
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-014
Total participants2013-01-018,314
Number of participants with account balances2013-01-016,481
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-01248
2012: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-017,335
Total number of active participants reported on line 7a of the Form 55002012-01-016,397
Number of retired or separated participants receiving benefits2012-01-0110
Number of other retired or separated participants entitled to future benefits2012-01-011,626
Total of all active and inactive participants2012-01-018,033
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-013
Total participants2012-01-018,036
Number of participants with account balances2012-01-016,168
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-01219
2011: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-017,343
Total number of active participants reported on line 7a of the Form 55002011-01-015,956
Number of retired or separated participants receiving benefits2011-01-018
Number of other retired or separated participants entitled to future benefits2011-01-011,806
Total of all active and inactive participants2011-01-017,770
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-012
Total participants2011-01-017,772
Number of participants with account balances2011-01-016,117
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-01221
2009: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-017,796
Total number of active participants reported on line 7a of the Form 55002009-01-015,688
Number of retired or separated participants receiving benefits2009-01-015
Number of other retired or separated participants entitled to future benefits2009-01-011,758
Total of all active and inactive participants2009-01-017,451
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-014
Total participants2009-01-017,455
Number of participants with account balances2009-01-016,032
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-01308

Financial Data on PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN

Measure Date Value
2022 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2022 401k financial data
Unrealized appreciation/depreciation of real estate assets2022-12-31$0
Unrealized appreciation/depreciation of other (non real estate) assets2022-12-31$0
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total transfer of assets to this plan2022-12-31$0
Total transfer of assets from this plan2022-12-31$3,558
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Expenses. Interest paid2022-12-31$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-1022022-12-31$0
Total income from all sources (including contributions)2022-12-31$-55,486,004
Total loss/gain on sale of assets2022-12-31$0
Total of all expenses incurred2022-12-31$102,282,999
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$101,252,401
Expenses. Certain deemed distributions of participant loans2022-12-31$14,983
Value of total corrective distributions2022-12-31$42,521
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$180,119,186
Value of total assets at end of year2022-12-31$1,209,616,750
Value of total assets at beginning of year2022-12-31$1,367,389,311
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$973,094
Total income from rents2022-12-31$0
Total interest from all sources2022-12-31$448,428
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$38,700,399
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$38,700,399
Assets. Real estate other than employer real property at end of year2022-12-31$0
Assets. Real estate other than employer real property at beginning of year2022-12-31$0
Administrative expenses professional fees incurred2022-12-31$0
Assets. Corporate prefeered stocks other than exployer securities at end of year2022-12-31$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year2022-12-31$0
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$10,000,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$114,201,557
Participant contributions at end of year2022-12-31$10,281,993
Participant contributions at beginning of year2022-12-31$8,456,570
Participant contributions at end of year2022-12-31$0
Participant contributions at beginning of year2022-12-31$0
Assets. Other investments not covered elsewhere at end of year2022-12-31$0
Assets. Other investments not covered elsewhere at beginning of year2022-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$29,052,261
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)2022-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at end of year2022-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2022-12-31$0
Assets. Loans (other than to participants) at end of year2022-12-31$0
Assets. Loans (other than to participants) at beginning of year2022-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2022-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2022-12-31$0
Other income not declared elsewhere2022-12-31$192,437
Administrative expenses (other) incurred2022-12-31$859,071
Liabilities. Value of operating payables at end of year2022-12-31$0
Liabilities. Value of operating payables at beginning of year2022-12-31$0
Total non interest bearing cash at end of year2022-12-31$0
Total non interest bearing cash at beginning of year2022-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Income. Non cash contributions2022-12-31$0
Value of net income/loss2022-12-31$-157,769,003
Value of net assets at end of year (total assets less liabilities)2022-12-31$1,209,616,750
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$1,367,389,311
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Assets. partnership/joint venture interests at end of year2022-12-31$0
Assets. partnership/joint venture interests at beginning of year2022-12-31$0
Investment advisory and management fees2022-12-31$114,023
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$1,145,599,958
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$1,315,135,131
Value of interest in pooled separate accounts at end of year2022-12-31$0
Value of interest in pooled separate accounts at beginning of year2022-12-31$0
Interest on participant loans2022-12-31$438,063
Income. Interest from loans (other than to participants)2022-12-31$0
Interest earned on other investments2022-12-31$0
Income. Interest from US Government securities2022-12-31$0
Income. Interest from corporate debt instruments2022-12-31$0
Value of interest in master investment trust accounts at end of year2022-12-31$0
Value of interest in master investment trust accounts at beginning of year2022-12-31$0
Value of interest in common/collective trusts at end of year2022-12-31$52,808,267
Value of interest in common/collective trusts at beginning of year2022-12-31$43,703,181
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2022-12-31$926,532
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2022-12-31$94,429
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2022-12-31$94,429
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2022-12-31$10,365
Assets. Value of investments in 103.12 investment entities at end of year2022-12-31$0
Assets. Value of investments in 103.12 investment entities at beginning of year2022-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2022-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2022-12-31$0
Expenses. Payments to insurance carriers foe the provision of benefits2022-12-31$0
Asset value of US Government securities at end of year2022-12-31$0
Asset value of US Government securities at beginning of year2022-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-275,905,951
Net investment gain/loss from pooled separate accounts2022-12-31$0
Net investment gain or loss from common/collective trusts2022-12-31$959,497
Net gain/loss from 103.12 investment entities2022-12-31$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31Yes
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Assets. Invements in employer securities at end of year2022-12-31$0
Assets. Invements in employer securities at beginning of year2022-12-31$0
Assets. Value of employer real property at end of year2022-12-31$0
Assets. Value of employer real property at beginning of year2022-12-31$0
Contributions received in cash from employer2022-12-31$36,865,368
Employer contributions (assets) at end of year2022-12-31$0
Employer contributions (assets) at beginning of year2022-12-31$0
Income. Dividends from preferred stock2022-12-31$0
Income. Dividends from common stock2022-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$101,252,401
Asset. Corporate debt instrument preferred debt at end of year2022-12-31$0
Asset. Corporate debt instrument preferred debt at beginning of year2022-12-31$0
Asset. Corporate debt instrument debt (other) at end of year2022-12-31$0
Asset. Corporate debt instrument debt (other) at beginning of year2022-12-31$0
Contract administrator fees2022-12-31$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32022-12-31No
Assets. Corporate common stocks other than exployer securities at end of year2022-12-31$0
Assets. Corporate common stocks other than exployer securities at beginning of year2022-12-31$0
Liabilities. Value of benefit claims payable at end of year2022-12-31$0
Liabilities. Value of benefit claims payable at beginning of year2022-12-31$0
Assets. Value of buildings and other operty used in plan operation at end of year2022-12-31$0
Assets. Value of buildings and other operty used in plan operation at beginning of year2022-12-31$0
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Aggregate proceeds on sale of assets2022-12-31$0
Aggregate carrying amount (costs) on sale of assets2022-12-31$0
Liabilities. Value of acquisition indebtedness at end of year2022-12-31$0
Liabilities. Value of acquisition indebtedness at beginning of year2022-12-31$0
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31PBMARES LLP
Accountancy firm EIN2022-12-31540737372
2021 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2021 401k financial data
Unrealized appreciation/depreciation of real estate assets2021-12-31$0
Unrealized appreciation/depreciation of other (non real estate) assets2021-12-31$0
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total transfer of assets to this plan2021-12-31$26,372,234
Total transfer of assets from this plan2021-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Expenses. Interest paid2021-12-31$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-1022021-12-31$0
Total income from all sources (including contributions)2021-12-31$335,581,816
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$115,306,468
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$114,148,542
Expenses. Certain deemed distributions of participant loans2021-12-31$145,488
Value of total corrective distributions2021-12-31$2,680
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$145,993,164
Value of total assets at end of year2021-12-31$1,367,389,311
Value of total assets at beginning of year2021-12-31$1,120,741,729
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$1,009,758
Total income from rents2021-12-31$0
Total interest from all sources2021-12-31$409,674
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$61,414,772
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$61,414,772
Assets. Real estate other than employer real property at end of year2021-12-31$0
Assets. Real estate other than employer real property at beginning of year2021-12-31$0
Administrative expenses professional fees incurred2021-12-31$0
Assets. Corporate prefeered stocks other than exployer securities at end of year2021-12-31$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year2021-12-31$0
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$10,000,000
If this is an individual account plan, was there a blackout period2021-12-31Yes
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$87,267,964
Participant contributions at end of year2021-12-31$8,456,570
Participant contributions at beginning of year2021-12-31$7,064,603
Participant contributions at end of year2021-12-31$0
Participant contributions at beginning of year2021-12-31$0
Assets. Other investments not covered elsewhere at end of year2021-12-31$0
Assets. Other investments not covered elsewhere at beginning of year2021-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$33,304,057
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)2021-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at end of year2021-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2021-12-31$0
Assets. Loans (other than to participants) at end of year2021-12-31$0
Assets. Loans (other than to participants) at beginning of year2021-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year2021-12-31$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year2021-12-31$0
Other income not declared elsewhere2021-12-31$205,174
Administrative expenses (other) incurred2021-12-31$989,428
Liabilities. Value of operating payables at end of year2021-12-31$0
Liabilities. Value of operating payables at beginning of year2021-12-31$0
Total non interest bearing cash at end of year2021-12-31$0
Total non interest bearing cash at beginning of year2021-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Income. Non cash contributions2021-12-31$0
Value of net income/loss2021-12-31$220,275,348
Value of net assets at end of year (total assets less liabilities)2021-12-31$1,367,389,311
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$1,120,741,729
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Assets. partnership/joint venture interests at end of year2021-12-31$0
Assets. partnership/joint venture interests at beginning of year2021-12-31$0
Investment advisory and management fees2021-12-31$20,330
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$1,315,135,131
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$1,068,071,425
Value of interest in pooled separate accounts at end of year2021-12-31$0
Value of interest in pooled separate accounts at beginning of year2021-12-31$0
Interest on participant loans2021-12-31$409,301
Income. Interest from loans (other than to participants)2021-12-31$0
Interest earned on other investments2021-12-31$0
Income. Interest from US Government securities2021-12-31$0
Income. Interest from corporate debt instruments2021-12-31$0
Value of interest in master investment trust accounts at end of year2021-12-31$0
Value of interest in master investment trust accounts at beginning of year2021-12-31$0
Value of interest in common/collective trusts at end of year2021-12-31$43,703,181
Value of interest in common/collective trusts at beginning of year2021-12-31$45,605,701
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2021-12-31$94,429
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2021-12-31$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2021-12-31$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2021-12-31$373
Assets. Value of investments in 103.12 investment entities at end of year2021-12-31$0
Assets. Value of investments in 103.12 investment entities at beginning of year2021-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2021-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2021-12-31$0
Expenses. Payments to insurance carriers foe the provision of benefits2021-12-31$0
Asset value of US Government securities at end of year2021-12-31$0
Asset value of US Government securities at beginning of year2021-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$126,770,640
Net investment gain/loss from pooled separate accounts2021-12-31$0
Net investment gain or loss from common/collective trusts2021-12-31$788,392
Net gain/loss from 103.12 investment entities2021-12-31$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31Yes
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Assets. Invements in employer securities at end of year2021-12-31$0
Assets. Invements in employer securities at beginning of year2021-12-31$0
Assets. Value of employer real property at end of year2021-12-31$0
Assets. Value of employer real property at beginning of year2021-12-31$0
Contributions received in cash from employer2021-12-31$25,421,143
Employer contributions (assets) at end of year2021-12-31$0
Employer contributions (assets) at beginning of year2021-12-31$0
Income. Dividends from preferred stock2021-12-31$0
Income. Dividends from common stock2021-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$114,148,542
Asset. Corporate debt instrument preferred debt at end of year2021-12-31$0
Asset. Corporate debt instrument preferred debt at beginning of year2021-12-31$0
Asset. Corporate debt instrument debt (other) at end of year2021-12-31$0
Asset. Corporate debt instrument debt (other) at beginning of year2021-12-31$0
Contract administrator fees2021-12-31$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32021-12-31Yes
Assets. Corporate common stocks other than exployer securities at end of year2021-12-31$0
Assets. Corporate common stocks other than exployer securities at beginning of year2021-12-31$0
Liabilities. Value of benefit claims payable at end of year2021-12-31$0
Liabilities. Value of benefit claims payable at beginning of year2021-12-31$0
Assets. Value of buildings and other operty used in plan operation at end of year2021-12-31$0
Assets. Value of buildings and other operty used in plan operation at beginning of year2021-12-31$0
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Aggregate proceeds on sale of assets2021-12-31$0
Aggregate carrying amount (costs) on sale of assets2021-12-31$0
Liabilities. Value of acquisition indebtedness at end of year2021-12-31$0
Liabilities. Value of acquisition indebtedness at beginning of year2021-12-31$0
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31PBMARES LLP
Accountancy firm EIN2021-12-31540737372
2020 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$263,394,273
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$66,155,837
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$65,197,623
Expenses. Certain deemed distributions of participant loans2020-12-31$68,356
Value of total corrective distributions2020-12-31$13,040
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$106,542,942
Value of total assets at end of year2020-12-31$1,120,741,729
Value of total assets at beginning of year2020-12-31$923,503,293
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$876,818
Total interest from all sources2020-12-31$382,602
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$34,271,347
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$34,271,347
Administrative expenses professional fees incurred2020-12-31$17,500
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$10,000,000
If this is an individual account plan, was there a blackout period2020-12-31No
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$70,106,250
Participant contributions at end of year2020-12-31$7,064,603
Participant contributions at beginning of year2020-12-31$6,919,014
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$15,638,270
Other income not declared elsewhere2020-12-31$822,053
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$197,238,436
Value of net assets at end of year (total assets less liabilities)2020-12-31$1,120,741,729
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$923,503,293
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Investment advisory and management fees2020-12-31$119,076
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$1,068,071,425
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$879,717,042
Interest on participant loans2020-12-31$382,602
Value of interest in common/collective trusts at end of year2020-12-31$45,605,701
Value of interest in common/collective trusts at beginning of year2020-12-31$36,867,237
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$120,487,344
Net investment gain or loss from common/collective trusts2020-12-31$887,985
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$20,798,422
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$65,197,623
Contract administrator fees2020-12-31$740,242
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Disclaimer
Accountancy firm name2020-12-31PBMARES LLP
Accountancy firm EIN2020-12-31540737372
2019 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$271,650,873
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$69,754,454
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$68,911,066
Expenses. Certain deemed distributions of participant loans2019-12-31$54,807
Value of total corrective distributions2019-12-31$24,860
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$92,941,231
Value of total assets at end of year2019-12-31$923,503,293
Value of total assets at beginning of year2019-12-31$721,606,874
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$763,721
Total interest from all sources2019-12-31$365,947
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$35,021,700
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$35,021,700
Administrative expenses professional fees incurred2019-12-31$19,120
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$10,000,000
If this is an individual account plan, was there a blackout period2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$59,146,671
Participant contributions at end of year2019-12-31$6,919,014
Participant contributions at beginning of year2019-12-31$6,738,715
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$15,989,863
Other income not declared elsewhere2019-12-31$663,867
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$201,896,419
Value of net assets at end of year (total assets less liabilities)2019-12-31$923,503,293
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$721,606,874
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Investment advisory and management fees2019-12-31$69,556
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$879,717,042
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$679,543,186
Interest on participant loans2019-12-31$365,947
Value of interest in common/collective trusts at end of year2019-12-31$36,867,237
Value of interest in common/collective trusts at beginning of year2019-12-31$35,324,973
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$141,853,579
Net investment gain or loss from common/collective trusts2019-12-31$804,549
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$17,804,697
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$68,911,066
Contract administrator fees2019-12-31$675,045
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31RSM US LLP
Accountancy firm EIN2019-12-31420714325
2018 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$32,284,867
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$56,254,482
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$55,387,664
Expenses. Certain deemed distributions of participant loans2018-12-31$115,183
Value of total corrective distributions2018-12-31$15,963
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$80,258,852
Value of total assets at end of year2018-12-31$721,606,874
Value of total assets at beginning of year2018-12-31$745,576,489
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$735,672
Total interest from all sources2018-12-31$318,598
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$38,984,449
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$38,984,449
Administrative expenses professional fees incurred2018-12-31$22,705
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$10,000,000
If this is an individual account plan, was there a blackout period2018-12-31No
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$53,687,136
Participant contributions at end of year2018-12-31$6,738,715
Participant contributions at beginning of year2018-12-31$6,610,286
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$10,542,105
Other income not declared elsewhere2018-12-31$716,296
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$-23,969,615
Value of net assets at end of year (total assets less liabilities)2018-12-31$721,606,874
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$745,576,489
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Investment advisory and management fees2018-12-31$90,378
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$679,543,186
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$707,837,353
Interest on participant loans2018-12-31$318,598
Value of interest in common/collective trusts at end of year2018-12-31$35,324,973
Value of interest in common/collective trusts at beginning of year2018-12-31$31,128,850
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-88,639,898
Net investment gain or loss from common/collective trusts2018-12-31$646,570
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$16,029,611
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$55,387,664
Contract administrator fees2018-12-31$622,589
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31RSM US LLP
Accountancy firm EIN2018-12-31420714325
2017 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$186,445,891
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$50,395,981
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$50,036,371
Expenses. Certain deemed distributions of participant loans2017-12-31$8,359
Value of total corrective distributions2017-12-31$11,768
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$76,883,107
Value of total assets at end of year2017-12-31$745,576,489
Value of total assets at beginning of year2017-12-31$609,526,579
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$339,483
Total interest from all sources2017-12-31$278,831
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$29,262,325
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$29,262,325
Administrative expenses professional fees incurred2017-12-31$35,184
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$10,000,000
If this is an individual account plan, was there a blackout period2017-12-31No
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$50,432,072
Participant contributions at end of year2017-12-31$6,610,286
Participant contributions at beginning of year2017-12-31$6,080,162
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$11,135,892
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2017-12-31$2,399,980
Other income not declared elsewhere2017-12-31$258,290
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$136,049,910
Value of net assets at end of year (total assets less liabilities)2017-12-31$745,576,489
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$609,526,579
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Investment advisory and management fees2017-12-31$109,283
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$707,837,353
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$569,116,398
Interest on participant loans2017-12-31$278,831
Value of interest in common/collective trusts at end of year2017-12-31$31,128,850
Value of interest in common/collective trusts at beginning of year2017-12-31$31,930,039
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$79,230,617
Net investment gain or loss from common/collective trusts2017-12-31$532,721
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$15,315,143
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$50,036,371
Contract administrator fees2017-12-31$195,016
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31RSM US LLP
Accountancy firm EIN2017-12-31420714325
2016 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total transfer of assets to this plan2016-12-31$2,399,980
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$121,014,575
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$39,995,133
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$39,698,318
Expenses. Certain deemed distributions of participant loans2016-12-31$132,287
Value of total corrective distributions2016-12-31$10,308
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$71,583,790
Value of total assets at end of year2016-12-31$609,526,579
Value of total assets at beginning of year2016-12-31$526,107,157
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$154,220
Total interest from all sources2016-12-31$237,927
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$16,952,346
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$16,952,346
Administrative expenses professional fees incurred2016-12-31$154,220
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$10,000,000
If this is an individual account plan, was there a blackout period2016-12-31No
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$45,198,156
Participant contributions at end of year2016-12-31$6,080,162
Participant contributions at beginning of year2016-12-31$5,550,908
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$12,664,490
Value of other receiveables (less allowance for doubtful accounts) at end of year2016-12-31$2,399,980
Other income not declared elsewhere2016-12-31$269,742
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$81,019,442
Value of net assets at end of year (total assets less liabilities)2016-12-31$609,526,579
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$526,107,157
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$569,116,398
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$491,598,400
Interest on participant loans2016-12-31$237,927
Value of interest in common/collective trusts at end of year2016-12-31$31,930,039
Value of interest in common/collective trusts at beginning of year2016-12-31$28,957,849
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$31,502,067
Net investment gain or loss from common/collective trusts2016-12-31$468,703
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$13,721,144
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$39,698,318
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31RSM US LLP
Accountancy firm EIN2016-12-31420714325
2015 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$61,018,159
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$36,095,912
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$35,784,209
Expenses. Certain deemed distributions of participant loans2015-12-31$187,388
Value of total corrective distributions2015-12-31$3,162
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$62,834,182
Value of total assets at end of year2015-12-31$526,107,157
Value of total assets at beginning of year2015-12-31$501,184,910
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$121,153
Total interest from all sources2015-12-31$214,774
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$24,867,302
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$24,867,302
Administrative expenses professional fees incurred2015-12-31$121,153
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$10,000,000
If this is an individual account plan, was there a blackout period2015-12-31No
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$40,504,472
Participant contributions at end of year2015-12-31$5,550,908
Participant contributions at beginning of year2015-12-31$4,750,205
Participant contributions at beginning of year2015-12-31$105
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$9,968,017
Other income not declared elsewhere2015-12-31$115,283
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$24,922,247
Value of net assets at end of year (total assets less liabilities)2015-12-31$526,107,157
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$501,184,910
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$491,598,400
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$469,711,929
Interest on participant loans2015-12-31$214,774
Value of interest in common/collective trusts at end of year2015-12-31$28,957,849
Value of interest in common/collective trusts at beginning of year2015-12-31$26,722,403
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-27,398,536
Net investment gain or loss from common/collective trusts2015-12-31$385,154
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$12,361,693
Employer contributions (assets) at beginning of year2015-12-31$268
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$35,784,209
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31RSM US LLP
Accountancy firm EIN2015-12-31420714325
2014 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$82,993,943
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$37,294,190
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$37,131,226
Expenses. Certain deemed distributions of participant loans2014-12-31$27,646
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$52,153,003
Value of total assets at end of year2014-12-31$501,184,910
Value of total assets at beginning of year2014-12-31$455,485,157
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$135,318
Total interest from all sources2014-12-31$193,730
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$27,017,408
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$27,017,408
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$10,000,000
If this is an individual account plan, was there a blackout period2014-12-31No
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$35,548,473
Participant contributions at end of year2014-12-31$4,750,205
Participant contributions at beginning of year2014-12-31$4,598,473
Participant contributions at end of year2014-12-31$105
Participant contributions at beginning of year2014-12-31$2,690
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$5,599,745
Other income not declared elsewhere2014-12-31$97,465
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$45,699,753
Value of net assets at end of year (total assets less liabilities)2014-12-31$501,184,910
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$455,485,157
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Investment advisory and management fees2014-12-31$81,680
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$469,711,929
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$424,218,839
Interest on participant loans2014-12-31$193,730
Value of interest in common/collective trusts at end of year2014-12-31$26,722,403
Value of interest in common/collective trusts at beginning of year2014-12-31$26,664,031
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$3,266,817
Net investment gain or loss from common/collective trusts2014-12-31$265,520
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$11,004,785
Employer contributions (assets) at end of year2014-12-31$268
Employer contributions (assets) at beginning of year2014-12-31$1,124
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$37,131,226
Contract administrator fees2014-12-31$53,638
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31MCGLADREY LLP
Accountancy firm EIN2014-12-31420714325
2013 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$126,525,998
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$22,450,357
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$22,398,182
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$47,966,024
Value of total assets at end of year2013-12-31$455,485,157
Value of total assets at beginning of year2013-12-31$351,409,516
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$52,175
Total interest from all sources2013-12-31$175,886
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$16,119,499
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$16,119,499
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$10,000,000
If this is an individual account plan, was there a blackout period2013-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$33,334,730
Participant contributions at end of year2013-12-31$4,598,473
Participant contributions at beginning of year2013-12-31$4,205,996
Participant contributions at end of year2013-12-31$2,690
Participant contributions at beginning of year2013-12-31$1,547
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$4,325,952
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$104,075,641
Value of net assets at end of year (total assets less liabilities)2013-12-31$455,485,157
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$351,409,516
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$424,218,839
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$321,885,699
Interest on participant loans2013-12-31$175,886
Value of interest in common/collective trusts at end of year2013-12-31$26,664,031
Value of interest in common/collective trusts at beginning of year2013-12-31$25,315,681
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$62,081,711
Net investment gain or loss from common/collective trusts2013-12-31$182,878
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$10,305,342
Employer contributions (assets) at end of year2013-12-31$1,124
Employer contributions (assets) at beginning of year2013-12-31$593
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$22,398,182
Contract administrator fees2013-12-31$52,175
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32013-12-31No
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31MCGLADREY LLP
Accountancy firm EIN2013-12-31420714325
2012 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$81,854,705
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$25,713,558
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$25,658,982
Expenses. Certain deemed distributions of participant loans2012-12-31$5,988
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$41,516,288
Value of total assets at end of year2012-12-31$351,409,516
Value of total assets at beginning of year2012-12-31$295,268,369
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$48,588
Total interest from all sources2012-12-31$166,527
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$9,075,679
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2012-12-31$9,075,679
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$10,000,000
If this is an individual account plan, was there a blackout period2012-12-31No
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$29,427,173
Participant contributions at end of year2012-12-31$4,205,996
Participant contributions at beginning of year2012-12-31$3,719,099
Participant contributions at end of year2012-12-31$1,547
Participant contributions at beginning of year2012-12-31$1,456
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$2,744,007
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2012-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$56,141,147
Value of net assets at end of year (total assets less liabilities)2012-12-31$351,409,516
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$295,268,369
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$321,885,699
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$267,575,759
Interest on participant loans2012-12-31$166,527
Value of interest in common/collective trusts at end of year2012-12-31$25,315,681
Value of interest in common/collective trusts at beginning of year2012-12-31$23,971,865
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$30,835,882
Net investment gain or loss from common/collective trusts2012-12-31$260,329
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$9,345,108
Employer contributions (assets) at end of year2012-12-31$593
Employer contributions (assets) at beginning of year2012-12-31$190
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$25,658,982
Contract administrator fees2012-12-31$48,588
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32012-12-31No
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31MCGLADREY LLP
Accountancy firm EIN2012-12-31420714325
2011 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets2011-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total income from all sources (including contributions)2011-12-31$35,744,843
Total loss/gain on sale of assets2011-12-31$0
Total of all expenses incurred2011-12-31$20,896,280
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$20,849,042
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$37,514,814
Value of total assets at end of year2011-12-31$295,268,369
Value of total assets at beginning of year2011-12-31$280,419,806
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$47,238
Total interest from all sources2011-12-31$160,117
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$7,108,831
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$7,108,831
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$6,000,000
If this is an individual account plan, was there a blackout period2011-12-31No
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$26,721,718
Participant contributions at end of year2011-12-31$3,719,099
Participant contributions at beginning of year2011-12-31$3,362,893
Participant contributions at end of year2011-12-31$1,456
Participant contributions at beginning of year2011-12-31$373
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$1,902,439
Value of other receiveables (less allowance for doubtful accounts) at end of year2011-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2011-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$14,848,563
Value of net assets at end of year (total assets less liabilities)2011-12-31$295,268,369
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$280,419,806
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$267,575,759
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$254,355,775
Interest on participant loans2011-12-31$160,117
Value of interest in common/collective trusts at end of year2011-12-31$23,971,865
Value of interest in common/collective trusts at beginning of year2011-12-31$22,700,662
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-9,231,477
Net investment gain or loss from common/collective trusts2011-12-31$192,558
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31No
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$8,890,657
Employer contributions (assets) at end of year2011-12-31$190
Employer contributions (assets) at beginning of year2011-12-31$103
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$20,849,042
Contract administrator fees2011-12-31$47,238
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32011-12-31No
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31Yes
Opinion of an independent qualified public accountant for this plan2011-12-31Disclaimer
Accountancy firm name2011-12-31MCGLADREY LLP
Accountancy firm EIN2011-12-31420714325
2010 : PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets2010-12-31$0
Total transfer of assets from this plan2010-12-31$1,798,927
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total income from all sources (including contributions)2010-12-31$65,288,311
Total loss/gain on sale of assets2010-12-31$0
Total of all expenses incurred2010-12-31$14,008,033
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$13,855,143
Expenses. Certain deemed distributions of participant loans2010-12-31$108,865
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$35,296,233
Value of total assets at end of year2010-12-31$280,419,806
Value of total assets at beginning of year2010-12-31$230,938,455
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$44,025
Total interest from all sources2010-12-31$154,743
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$4,673,551
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2010-12-31$4,673,551
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$6,000,000
If this is an individual account plan, was there a blackout period2010-12-31No
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$25,444,957
Participant contributions at end of year2010-12-31$3,362,893
Participant contributions at beginning of year2010-12-31$2,702,578
Participant contributions at end of year2010-12-31$373
Participant contributions at beginning of year2010-12-31$21,729
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$1,223,076
Value of other receiveables (less allowance for doubtful accounts) at end of year2010-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2010-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$51,280,278
Value of net assets at end of year (total assets less liabilities)2010-12-31$280,419,806
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$230,938,455
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$254,355,775
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$205,959,327
Interest on participant loans2010-12-31$154,743
Value of interest in common/collective trusts at end of year2010-12-31$22,700,662
Value of interest in common/collective trusts at beginning of year2010-12-31$22,249,542
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$24,977,684
Net investment gain or loss from common/collective trusts2010-12-31$186,100
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31No
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$8,628,200
Employer contributions (assets) at end of year2010-12-31$103
Employer contributions (assets) at beginning of year2010-12-31$5,279
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$13,855,143
Contract administrator fees2010-12-31$44,025
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32010-12-31No
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31MCGLADREY & PULLEN, LLP
Accountancy firm EIN2010-12-31420714325

Form 5500 Responses for PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN

2022: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Submission has been amendedNo
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement - TrustYes
2021: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement - TrustYes
2020: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement - TrustYes
2019: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement - TrustYes
2018: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement - TrustYes
2017: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement - TrustYes
2016: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement - TrustYes
2015: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement - TrustYes
2014: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement - TrustYes
2013: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedNo
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement - TrustYes
2012: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2009: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC RETIREMENT SAVINGS PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement - TrustYes

Potentially related plans

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3